TrialPanorama/TrialPanorama-database huggingface dataset:
Study 21354370 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 19406658 — Surrogate Endpoint (SUR): Blood pressure
Study 25296725 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study 25296725 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 17544264 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 8035028 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30372675 — Predictive Biomarker (PRD): L1CAM mRNA
Genes: L1CAM; CAML1; MIC5
Study 30372675 — Predictive Biomarker (PRD): NRGN mRNA
Genes: NRGN
Study 30372675 — Pharmacodynamic Biomarker (PDY): Neuromodulin
Genes: GAP43
Study 11872674 — Surrogate Endpoint (SUR): Blood pressure
Study 21144505 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21144505 — Surrogate Endpoint (SUR): Blood pressure
Study 18083781 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study 8241095 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2862810 — Surrogate Endpoint (SUR): Blood pressure
Study 31881614 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 26630547 — Predictive Biomarker (PRD): SERPINA2 mRNA
Genes: SERPINA2; ARGS; ATR; PIL; SERPINA2P
Study 26541842 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 31907186 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 22206795 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22206795 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22206795 — Surrogate Endpoint (SUR): Serum creatinine
Study 12364632 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29975270 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 10502590 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9712239 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 9712239 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26195265 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 21348806 — Surrogate Endpoint (SUR): Blood pressure
Study 14614218 — Surrogate Endpoint (SUR): Bone mineral density
Study 4082295 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 21265353 — Surrogate Endpoint (SUR): Blood pressure
Study 15591305 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 6365409 — Surrogate Endpoint (SUR): Blood pressure
Study 28602779 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 25989338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24099474 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 17000930 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17000930 — Surrogate Endpoint (SUR): Blood pressure
Study 3116132 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26599376 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 23820669 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 23820669 — Predictive Biomarker (PRD): Hormone receptor
Study 23820669 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 19238075 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12602908 — Predictive Biomarker (PRD): DCT mRNA
Genes: DCT; TYRP2
Study 8350342 — Surrogate Endpoint (SUR): Blood pressure
Study 22987918 — Predictive Biomarker (PRD): SLC4A5 mRNA
Genes: SLC4A5; NBC4
Study 22987918 — Predictive Biomarker (PRD): GRK4 mRNA
Genes: GRK4; GPRK2L; GPRK4
Study 18949104 — Surrogate Endpoint (SUR): Blood pressure
Study 10849524 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 28724547 — Surrogate Endpoint (SUR): Blood pressure
Study 25538178 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 23161001 — Surrogate Endpoint (SUR): Blood pressure
Study 19238452 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16918945 — Surrogate Endpoint (SUR): Blood pressure
Study 23569311 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 23569311 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 23569311 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19500335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28535076 — Safety Biomarker (SAF): Hyaluronic acid
Study 23122652 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 18075302 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 18075302 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 18075302 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 15625138 — Surrogate Endpoint (SUR): Blood pressure
Study 12163426 — Surrogate Endpoint (SUR): Blood pressure
Study 8942423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8942423 — Safety Biomarker (SAF): Interleukin 1
Study 8942423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7950459 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30387374 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 20470671 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20470671 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20470671 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15998268 — Surrogate Endpoint (SUR): Probing pocket depth
Study 11094001 — Surrogate Endpoint (SUR): Blood pressure
Study 9010701 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 28106552 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 21931077 — Surrogate Endpoint (SUR): Blood pressure
Study 19145932 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8941507 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 8941507 — Surrogate Endpoint (SUR): Blood pressure
Study 30796338 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15019892 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11260155 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 11260155 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9731049 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 17897105 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12688516 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 31833102 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 24034663 — Surrogate Endpoint (SUR): Blood pressure
Study 9333933 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8002621 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31421060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28112681 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 28112681 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28112681 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 18820779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18820779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24707022 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 20350619 — Surrogate Endpoint (SUR): Blood pressure
Study 7781662 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 23478248 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study 17449250 — Surrogate Endpoint (SUR): Pathological complete response
Study 15386160 — Surrogate Endpoint (SUR): Bone mineral density
Study 8196289 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8196289 — Surrogate Endpoint (SUR): Blood pressure
Study 24821586 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 22552566 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22552566 — Surrogate Endpoint (SUR): Serum creatinine
Study 20084279 — Predictive Biomarker (PRD): OAS3 mRNA
Genes: OAS3; P/OKcl.4
Study 20084279 — Predictive Biomarker (PRD): SULF1 mRNA
Genes: SULF1; KIAA1077
Study 20084279 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 20084279 — Predictive Biomarker (PRD): DUT mRNA
Genes: DUT
Study 20084279 — Predictive Biomarker (PRD): TMC6 mRNA
Genes: TMC6; EVER1; EVIN1
Study 20084279 — Predictive Biomarker (PRD): TMC8 mRNA
Genes: TMC8; EVER2; EVIN2
Study 18711936 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 17045906 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 31985746 — Surrogate Endpoint (SUR): Blood pressure
Study 12461301 — Surrogate Endpoint (SUR): Blood pressure
Study 1861474 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 1861474 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 23947690 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 23947690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23947690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23947690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7977319 — Surrogate Endpoint (SUR): Serum creatinine
Study 7977319 — Surrogate Endpoint (SUR): Blood pressure
Study 31743394 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 22126894 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 20616786 — Surrogate Endpoint (SUR): Blood pressure
Study 17289888 — Predictive Biomarker (PRD): PCA3
Study 15781340 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 15781340 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2540650 — Surrogate Endpoint (SUR): Blood pressure
Study 2540650 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 30528828 — Predictive Biomarker (PRD): S100A7 mRNA
Genes: S100A7; PSOR1; S100A7C
Study 23591293 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 2667310 — Surrogate Endpoint (SUR): Blood pressure
Study 28244906 — Surrogate Endpoint (SUR): Bone mineral density
Study 23510092 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 21223344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11304902 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 7902021 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 29851569 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 27256922 — Predictive Biomarker (PRD): CD200R1 mRNA
Genes: CD200R1; CD200R; CRTR2; MOX2R; OX2R; UNQ2522/PRO6015
Study 23165467 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16630150 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 8349803 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8349803 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 27543252 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 21953589 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31876029 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 19660462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19660462 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 19660462 — Safety Biomarker (SAF): Interleukin 12
Study 17134849 — Surrogate Endpoint (SUR): Blood pressure
Study 7880610 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 3709639 — Surrogate Endpoint (SUR): Blood pressure
Study 14730657 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 9068935 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 9068935 — Safety Biomarker (SAF): CYP3A4
Genes: CYP3A3
Study 8415898 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 8415898 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 15637746 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 9522242 — Surrogate Endpoint (SUR): Serum calcium
Study 31444140 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15514192 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15514192 — Surrogate Endpoint (SUR): Blood pressure
Study 15514192 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2406228 — Predictive Biomarker (PRD): NOG mRNA
Genes: NOG
Study 6768079 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 24787908 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 24787908 — Surrogate Endpoint (SUR): Blood pressure
Study 31794968 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 28170279 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 25579717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25579717 — Surrogate Endpoint (SUR): Serum creatinine
Study 25579717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24016832 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study 9933475 — Surrogate Endpoint (SUR): Bone mineral density
Study 31738468 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 22414624 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 20506226 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 8707164 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 6133303 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 6133303 — Surrogate Endpoint (SUR): Blood pressure
Study 29724865 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 18650514 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 18262432 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 18262432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25908682 — Surrogate Endpoint (SUR): Bone mineral density
Study 19752472 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 3422261 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 3422261 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30797045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23456672 — Surrogate Endpoint (SUR): Bone mineral density
Study 17367356 — Surrogate Endpoint (SUR): Serum creatinine
Study 7657122 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 15148064 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 3548301 — Surrogate Endpoint (SUR): Blood pressure
Study 16269047 — Surrogate Endpoint (SUR): Serum creatinine
Study 12006915 — Surrogate Endpoint (SUR): Serum alkaline phosphatase and bilirubin
Study 19452376 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 15994253 — Surrogate Endpoint (SUR): Forced vital capacity
Study 8686816 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8686816 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 6633131 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 28537652 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 28537652 — Predictive Biomarker (PRD): AFM mRNA
Genes: AFM; ALB2; ALBA
Study 11952509 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8587482 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 8587482 — Predictive Biomarker (PRD): ERCC8 mRNA
Genes: ERCC8; CKN1; CSA
Study 8587482 — Surrogate Endpoint (SUR): Forced vital capacity
Study 2676872 — Surrogate Endpoint (SUR): Blood pressure
Study 23221573 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study 23221573 — Predictive Biomarker (PRD): FADS2 mRNA
Genes: FADS2
Study 20666881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10797611 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 8866385 — Surrogate Endpoint (SUR): Blood pressure
Study 31722585 — Monitoring Biomarker (MOI): Cell-free DNA
Study 29231408 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20625026 — Surrogate Endpoint (SUR): Blood pressure
Study 16652049 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26410591 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 26410591 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11026626 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15820798 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 15820798 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 28049736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28049736 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 28049736 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 28049736 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 11216145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11216145 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29135601 — Surrogate Endpoint (SUR): Blood pressure
Study 26304156 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 22748043 — Predictive Biomarker (PRD): SPSB3 mRNA
Genes: SPSB3; C16orf31; SSB3
Study 22748043 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 16287372 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 8950804 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 24620913 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study 26016866 — Surrogate Endpoint (SUR): Blood pressure
Study 21733046 — Surrogate Endpoint (SUR): Blood pressure
Study 17229426 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12924797 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 6115521 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 20090429 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20090429 — Surrogate Endpoint (SUR): Blood pressure
Study 16187917 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2223741 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 28504033 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 28504033 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25844857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25844857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16676705 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16676705 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 1514322 — Surrogate Endpoint (SUR): Blood pressure
Study 31084656 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 21804061 — Surrogate Endpoint (SUR): Bacterial count
Study 14647985 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 11707007 — Surrogate Endpoint (SUR): Bone mineral density
Study 24160205 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24160205 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 24160205 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study 24160205 — Surrogate Endpoint (SUR): Blood pressure
Study 16434427 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 2193461 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 6432398 — Surrogate Endpoint (SUR): Blood pressure
Study 30580082 — Predictive Biomarker (PRD): miR-23a-3p
Genes: MIR23A
Study 30580082 — Safety Biomarker (SAF): miR-16
Study 30580082 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 30580082 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 16041193 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16041193 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10568224 — Surrogate Endpoint (SUR): Bone mineral density
Study 7725591 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 7725591 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7725591 — Predictive Biomarker (PRD): SIGLEC1 mRNA
Genes: SIGLEC1; SN
Study 7725591 — Predictive Biomarker (PRD): TMEM37 mRNA
Genes: TMEM37; PR
Study 31140343 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB